位置:首页 > 蛋白库 > VEZA_MOUSE
VEZA_MOUSE
ID   VEZA_MOUSE              Reviewed;         780 AA.
AC   Q3ZK22; A0M8X3; Q3ZK21; Q8BY12; Q8BYB4; Q8BZB5;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   02-SEP-2008, sequence version 2.
DT   03-AUG-2022, entry version 108.
DE   RecName: Full=Vezatin {ECO:0000305};
GN   Name=Vezt {ECO:0000312|MGI:MGI:2143698};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), DEVELOPMENTAL STAGE,
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RC   STRAIN=129S2/SvPas;
RX   PubMed=16199027; DOI=10.1016/j.ydbio.2005.09.004;
RA   Hyenne V., Louvet-Vallee S., El-Amraoui A., Petit C., Maro B.,
RA   Simmler M.-C.;
RT   "Vezatin, an ubiquitous adherens junction protein, is required for mouse
RT   blastocyst morphogenesis.";
RL   Dev. Biol. 287:180-191(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), DISRUPTION PHENOTYPE, AND FUNCTION.
RC   STRAIN=129S2/SvPas;
RX   PubMed=17452094; DOI=10.1016/j.mod.2007.03.004;
RA   Hyenne V., Souilhol C., Cohen-Tannoudji M., Cereghini S., Petit C.,
RA   Langa F., Maro B., Simmler M.-C.;
RT   "Conditional knock-out reveals that zygotic vezatin-null mouse embryos die
RT   at implantation.";
RL   Mech. Dev. 124:449-462(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 4).
RC   STRAIN=C57BL/6J; TISSUE=Cerebellum, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND INTERACTION WITH USH2A.
RX   PubMed=17567809; DOI=10.1523/jneurosci.0342-07.2007;
RA   Michalski N., Michel V., Bahloul A., Lefevre G., Barral J., Yagi H.,
RA   Chardenoux S., Weil D., Martin P., Hardelin J.P., Sato M., Petit C.;
RT   "Molecular characterization of the ankle-link complex in cochlear hair
RT   cells and its role in the hair bundle functioning.";
RL   J. Neurosci. 27:6478-6488(2007).
RN   [6]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=17379651; DOI=10.1530/rep-06-0271;
RA   Hyenne V., Harf J.C., Latz M., Maro B., Wolfrum U., Simmler M.-C.;
RT   "Vezatin, a ubiquitous protein of adherens cell-cell junctions, is
RT   exclusively expressed in germ cells in mouse testis.";
RL   Reproduction 133:563-574(2007).
CC   -!- FUNCTION: Plays a pivotal role in the establishment of adherens
CC       junctions and their maintenance in adult life. Required for
CC       morphogenesis of the preimplantation embryo, and for the implantation
CC       process. {ECO:0000269|PubMed:16199027, ECO:0000269|PubMed:17452094}.
CC   -!- SUBUNIT: Interacts with USH2A (via the cytoplasmic region); the
CC       interaction associates VEZT with the USH2 complex at the stereocilia
CC       base (PubMed:17567809). Interacts with myosin MYO7A and the cadherin-
CC       catenins complex (By similarity). {ECO:0000250|UniProtKB:Q9HBM0,
CC       ECO:0000269|PubMed:17567809}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16199027};
CC       Multi-pass membrane protein {ECO:0000305}. Cell projection,
CC       stereocilium membrane {ECO:0000269|PubMed:17567809}. Cell junction,
CC       adherens junction {ECO:0000269|PubMed:16199027}. Nucleus
CC       {ECO:0000269|PubMed:16199027}. Cytoplasmic vesicle, secretory vesicle,
CC       acrosome {ECO:0000269|PubMed:17379651}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=2.4;
CC         IsoId=Q3ZK22-1; Sequence=Displayed;
CC       Name=2; Synonyms=0.8;
CC         IsoId=Q3ZK22-2; Sequence=VSP_035268, VSP_035269, VSP_035270;
CC       Name=3; Synonyms=1.9;
CC         IsoId=Q3ZK22-3; Sequence=VSP_035272, VSP_035273;
CC       Name=4;
CC         IsoId=Q3ZK22-4; Sequence=VSP_035271, VSP_035274;
CC   -!- TISSUE SPECIFICITY: Expressed in developing cochlear hair cells
CC       (PubMed:17567809). Isoform 1, isoform 2 and isoform 3 are expressed in
CC       testis. In the seminiferous epithelium, present exclusively in the
CC       acrosome of spermatids (at protein level).
CC       {ECO:0000269|PubMed:17379651, ECO:0000269|PubMed:17567809}.
CC   -!- DEVELOPMENTAL STAGE: Present in oocytes and at every embryonic stage
CC       (at protein level). {ECO:0000269|PubMed:16199027}.
CC   -!- DISRUPTION PHENOTYPE: Embryos die at the time of implantation because
CC       of a defect in intercellular adhesion. {ECO:0000269|PubMed:17452094}.
CC   -!- SIMILARITY: Belongs to the vezatin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY753561; AAX12551.1; -; mRNA.
DR   EMBL; AY753562; AAX12552.1; -; mRNA.
DR   EMBL; DQ025533; AAY87458.1; -; mRNA.
DR   EMBL; AK036017; BAC29277.1; -; mRNA.
DR   EMBL; AK041354; BAC30915.1; -; mRNA.
DR   EMBL; AK042540; BAC31287.1; -; mRNA.
DR   EMBL; BC056428; AAH56428.1; -; mRNA.
DR   CCDS; CCDS36038.1; -. [Q3ZK22-1]
DR   CCDS; CCDS78886.1; -. [Q3ZK22-3]
DR   CCDS; CCDS83750.1; -. [Q3ZK22-4]
DR   RefSeq; NP_001291501.1; NM_001304572.1. [Q3ZK22-3]
DR   RefSeq; NP_001291504.1; NM_001304575.1.
DR   RefSeq; NP_001291649.1; NM_001304720.1. [Q3ZK22-4]
DR   RefSeq; NP_766126.2; NM_172538.5. [Q3ZK22-1]
DR   AlphaFoldDB; Q3ZK22; -.
DR   SMR; Q3ZK22; -.
DR   BioGRID; 229587; 1.
DR   STRING; 10090.ENSMUSP00000037955; -.
DR   iPTMnet; Q3ZK22; -.
DR   PhosphoSitePlus; Q3ZK22; -.
DR   SwissPalm; Q3ZK22; -.
DR   EPD; Q3ZK22; -.
DR   MaxQB; Q3ZK22; -.
DR   PaxDb; Q3ZK22; -.
DR   PeptideAtlas; Q3ZK22; -.
DR   PRIDE; Q3ZK22; -.
DR   ProteomicsDB; 297976; -. [Q3ZK22-1]
DR   ProteomicsDB; 297977; -. [Q3ZK22-2]
DR   ProteomicsDB; 297978; -. [Q3ZK22-3]
DR   ProteomicsDB; 297979; -. [Q3ZK22-4]
DR   Antibodypedia; 1345; 64 antibodies from 23 providers.
DR   DNASU; 215008; -.
DR   Ensembl; ENSMUST00000047711; ENSMUSP00000037955; ENSMUSG00000036099. [Q3ZK22-1]
DR   Ensembl; ENSMUST00000118077; ENSMUSP00000113983; ENSMUSG00000036099. [Q3ZK22-3]
DR   Ensembl; ENSMUST00000118205; ENSMUSP00000113321; ENSMUSG00000036099. [Q3ZK22-4]
DR   Ensembl; ENSMUST00000150704; ENSMUSP00000121727; ENSMUSG00000036099. [Q3ZK22-2]
DR   GeneID; 215008; -.
DR   KEGG; mmu:215008; -.
DR   UCSC; uc007gvh.2; mouse. [Q3ZK22-1]
DR   UCSC; uc007gvi.2; mouse. [Q3ZK22-3]
DR   UCSC; uc007gvj.2; mouse. [Q3ZK22-2]
DR   UCSC; uc056yhx.1; mouse. [Q3ZK22-4]
DR   CTD; 55591; -.
DR   MGI; MGI:2143698; Vezt.
DR   VEuPathDB; HostDB:ENSMUSG00000036099; -.
DR   eggNOG; ENOG502QTQW; Eukaryota.
DR   GeneTree; ENSGT00390000003290; -.
DR   HOGENOM; CLU_019876_2_0_1; -.
DR   InParanoid; Q3ZK22; -.
DR   OMA; IVCENPR; -.
DR   OrthoDB; 1379096at2759; -.
DR   PhylomeDB; Q3ZK22; -.
DR   TreeFam; TF332269; -.
DR   BioGRID-ORCS; 215008; 14 hits in 61 CRISPR screens.
DR   ChiTaRS; Vezt; mouse.
DR   PRO; PR:Q3ZK22; -.
DR   Proteomes; UP000000589; Chromosome 10.
DR   RNAct; Q3ZK22; protein.
DR   Bgee; ENSMUSG00000036099; Expressed in superior cervical ganglion and 236 other tissues.
DR   ExpressionAtlas; Q3ZK22; baseline and differential.
DR   Genevisible; Q3ZK22; MM.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005912; C:adherens junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0002142; C:stereocilia ankle link complex; IDA:MGI.
DR   GO; GO:0060171; C:stereocilium membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0017022; F:myosin binding; IEA:InterPro.
DR   GO; GO:0098609; P:cell-cell adhesion; IMP:MGI.
DR   GO; GO:0043009; P:chordate embryonic development; IMP:MGI.
DR   InterPro; IPR026859; Myosin-bd.
DR   InterPro; IPR026858; Vezatin.
DR   PANTHER; PTHR15989; PTHR15989; 1.
DR   Pfam; PF12632; Vezatin; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Cell projection;
KW   Coiled coil; Cytoplasmic vesicle; Developmental protein; Membrane; Nucleus;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..780
FT                   /note="Vezatin"
FT                   /id="PRO_0000349248"
FT   TRANSMEM        140..160
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        162..182
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REGION          620..718
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          757..780
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          430..467
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        620..639
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        640..664
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        760..780
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         239..307
FT                   /note="SAACSFNKAAQHPGQHLIGLRKAVYRTVRANFQAARLATLYMLKNYPLNSES
FT                   DNVTNYICVVPFKELGL -> LLR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072,
FT                   ECO:0000303|PubMed:17452094"
FT                   /id="VSP_035268"
FT   VAR_SEQ         311..342
FT                   /note="EDQISEEEARNLTDGFSLPALKVLFQLWVAQS -> DEWLCAQPVLRQVYQM
FT                   LGLVSFLTFTHIMDLT (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072,
FT                   ECO:0000303|PubMed:17452094"
FT                   /id="VSP_035269"
FT   VAR_SEQ         343..780
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072,
FT                   ECO:0000303|PubMed:17452094"
FT                   /id="VSP_035270"
FT   VAR_SEQ         611..639
FT                   /note="AVLTSLSPVDPVESVSNSEPPMNSDTEKV -> EWTFNWIHHAGHGGTVIPA
FT                   RWLRQGGSGV (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_035271"
FT   VAR_SEQ         611..617
FT                   /note="AVLTSLS -> GVKAEWN (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16199027"
FT                   /id="VSP_035272"
FT   VAR_SEQ         618..780
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16199027"
FT                   /id="VSP_035273"
FT   VAR_SEQ         640..780
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_035274"
FT   CONFLICT        57
FT                   /note="R -> K (in Ref. 1; AAX12552/AAX12551 and 2;
FT                   AAY87458)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        74
FT                   /note="S -> P (in Ref. 1; AAX12552/AAX12551 and 2;
FT                   AAY87458)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        177
FT                   /note="F -> L (in Ref. 1; AAX12552/AAX12551 and 2;
FT                   AAY87458)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        358
FT                   /note="S -> T (in Ref. 1; AAX12552)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        390
FT                   /note="D -> E (in Ref. 1; AAX12552/AAX12551)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   780 AA;  87987 MW;  AB8D244A6EDBDCEE CRC64;
     MTPEFDEEVV FENSPLYQYL QDLGHTDFEI CSSSSPKPEK CLTTEGPQPP PTRVLQRQGI
     LLKLTETIKS WTFSSQHSKK DDLLHKLDTG FRLDSLHTIL QQEVLLQEDV ELLELLDASI
     LSAGQPQQES GHLPTLCSLA TPNTWDVSLL FAFISLLIMF PTCWIVSSWL VWGIILFLYL
     IIRVLKLWRT AKLQMTLKKY RVRLEDMAAN SRAFTNLVRK SLRLIQETEV ISRGFTLVSA
     ACSFNKAAQH PGQHLIGLRK AVYRTVRANF QAARLATLYM LKNYPLNSES DNVTNYICVV
     PFKELGLGLS EDQISEEEAR NLTDGFSLPA LKVLFQLWVA QSSEFFRRLA LLLSTANSPS
     GPLLTAALLP HHILCDVTQG LPHAHSACLD ELKRSYEFFR YFETQHQSVP QRLSKTPQKS
     RELSNVHTAV RSLQLHLKAL LNEVIILEDE LEKLVCTKET QELLSEAYPI LEQKLKLIEP
     HVQASNSCWE EAISQVDKLL RRNTDKKGKP GVACENPHCT AEPLVRPALH IEDRDPIPEE
     QELEAYVDDI DIESEFRKDD FYHLSQEDRE RQKREQEESR RVLQELKSVL GFKASEAERQ
     KWKQLLFSDH AVLTSLSPVD PVESVSNSEP PMNSDTEKVN SNATEEETSK PCAGDKEDSR
     TEYVCDSPTE GPSKDTSADT GLLLPGAEET MCHQHESEAK SPQAAAAGAT APPTPRDTLQ
     LSIKQRLARL QLPPEFTFSA GLAAEVAARS LSFTTMQEQT FGDEEEEQLV EGGENEVEEK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024